Who makes [14C]-GSK3191607?

[14C]-GSK3191607 is developed by GlaxoSmithKline.

What development phase is [14C]-GSK3191607 in?

[14C]-GSK3191607 is in Phase 1.

Last reviewed 2026-05-14 · How we verify

[14C]-GSK3191607

GlaxoSmithKline · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[14C]-GSK3191607
Sponsor	GlaxoSmithKline
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-GSK3191607 CI brief — competitive landscape report
[14C]-GSK3191607 updates RSS · CI watch RSS
GlaxoSmithKline portfolio CI